The prevalence of prescriptions and their indications

Canadian Journal of Psychiatry

Volumn 55, Issue 11, 2010, Pages 709-711

  El Guebaly, Nady ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

DRUG INDICATION; DRUG USE; DRUG WITHDRAWAL; FATIGUE; HIGH RISK PATIENT; HUMAN; MEMORY DISORDER; PRESCRIPTION; PREVALENCE; RESPONSIBILITY; SEDATION; SHORT SURVEY; SIDE EFFECT; SLURRED SPEECH; WEAKNESS;

EID: 78549290381     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Neutel CI. The epidemiology of long-term benzodiazeopine use. Int Rev Psychiatry. 2005;17:189-197.
2. Demyttenaere K, Bonnewyn A, Bruffaerts R, et al. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Affect Disord. 2008;110(1-2):84-93.
3. Windle A, Elliot E, Duszynski K, et al. Benzodiazepine prescribing in elderly Australian general practice patients. Aust N Z J Public Health. 2007;31:379-381. (Pubitemid 47278126)
4. Hollister LE, Muller-Oerlinghausen B, Rickels K, et al. Clinical uses of benzodiazepines. J Clin Psychopharmacol. 1993;13:1S-169S.
5. Lister RG. The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev. 1985;9:87-94.
6. Bisaga A. Benzodiazepines and other sedatives and hypnotics. In: Galanter M, Kleber HD, editors. Textbook of substance abuse treatment. Washington (DC): American Psychiatric Publishing, Inc; 2008. p 215-235.
7. Kendler KS, Karkowski LM, Neale MC, et al. Illicit psychoactive substance use, heavy use, abuse and dependence in a US population-based sample of male twins. Arch Gen Psychiatry. 2000;57:261-269.
8. Soumerai SB, Simoni-Wastila L, Singer C, et al. Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatr Serv. 2003;54:1006-1011. (Pubitemid 36793455)
9. Substance Abuse and Mental Health Services Administration (SAMHSA). Treatment Episode Data Set (TEDS): 1995-2005; national admissions to substance abuse treatment services. Series S-37 (DHHS no SMA-07-4234). Rockville (MD): SAMHSA; 2007.
10. American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry. 1998;155(5 Suppl):1-34. (Pubitemid 28211237)
11. National Institute for Health and Clinical Excellence. Management of anxiety (panic disorder with or without agoraphobia, and generalized anxiety disorder) in adults in primary, secondary and community care [Internet]. London (GB): NICE; 2004 [updated 2007; cited 2009 Oct 19]. Available from: http://www.nice.org.uk/guidance/CG22.
12. Dunlop BW, Davis PG. Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review. Prim Care Companion J Clin Psychiatry. 2008;10:222-228.
13. Ashton CH. Benzodiazepines: how they work and how to withdraw [Internet] [also known as the Ashton manual]. [Updated 2002 Aug; cited 2008 Oct 20]. Available from: http://www.benzo.org.uk/manual/index.htm.